HK1249440A1 - 具有改善的儲存穩定性的藥物組合物及其製備方法 - Google Patents

具有改善的儲存穩定性的藥物組合物及其製備方法

Info

Publication number
HK1249440A1
HK1249440A1 HK18109125.9A HK18109125A HK1249440A1 HK 1249440 A1 HK1249440 A1 HK 1249440A1 HK 18109125 A HK18109125 A HK 18109125A HK 1249440 A1 HK1249440 A1 HK 1249440A1
Authority
HK
Hong Kong
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Application number
HK18109125.9A
Other languages
English (en)
Inventor
Bong Oh Kim
Kyu Jin Kyung
Ji Yeong Kim
Hye Rim Kim
Bum Chan MIN
Yoo Jeong YOON
Min Hyo Seo
Yil Woong Yi
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of HK1249440A1 publication Critical patent/HK1249440A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK18109125.9A 2015-07-28 2018-07-13 具有改善的儲存穩定性的藥物組合物及其製備方法 HK1249440A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150106628A KR101787447B1 (ko) 2015-07-28 2015-07-28 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법
PCT/KR2016/008269 WO2017018819A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
HK1249440A1 true HK1249440A1 (zh) 2018-11-02

Family

ID=57884931

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109125.9A HK1249440A1 (zh) 2015-07-28 2018-07-13 具有改善的儲存穩定性的藥物組合物及其製備方法

Country Status (13)

Country Link
EP (1) EP3328436A4 (zh)
JP (1) JP2018521106A (zh)
KR (1) KR101787447B1 (zh)
CN (1) CN106659680A (zh)
AU (1) AU2016299547A1 (zh)
BR (1) BR112018001719A2 (zh)
CA (1) CA2993923A1 (zh)
HK (1) HK1249440A1 (zh)
IL (1) IL257181A (zh)
MX (1) MX2018001222A (zh)
RU (1) RU2018107054A (zh)
WO (1) WO2017018819A1 (zh)
ZA (1) ZA201801186B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190231689A1 (en) * 2018-01-29 2019-08-01 Samyang Biopharmaceuticals Corporation Amphiphilic Block Copolymer Composition With Enhanced Micelle Stability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280557B1 (en) * 2000-05-12 2012-06-20 Samyang Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
NZ532198A (en) * 2001-10-18 2006-03-31 Samyang Corp Polymeric micelle composition of an amphiphilic block copolymer and a polylactic acid derivative
ATE487134T1 (de) 2007-03-06 2010-11-15 Cell Therapeutics Europe Srl Verfahren zur bestimmung der menge konjugierten taxans in polyglutaminsäure-taxan-konjugaten
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
RU2459840C2 (ru) * 2007-12-31 2012-08-27 Самъянг Корпорейшн АМФИФИЛЬНЫЙ СОПОЛИМЕР ВЫСОКОЙ ЧИСТОТЫ, СОДЕРЖАЩИЙ ГИДРОФОБНЫЙ БЛОК ИЗ α-ГИДРОКСИКИСЛОТЫ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same

Also Published As

Publication number Publication date
EP3328436A1 (en) 2018-06-06
MX2018001222A (es) 2018-04-24
RU2018107054A (ru) 2019-08-28
BR112018001719A2 (pt) 2018-09-18
KR101787447B1 (ko) 2017-10-19
CA2993923A1 (en) 2017-02-02
EP3328436A4 (en) 2019-03-20
AU2016299547A1 (en) 2018-02-22
IL257181A (en) 2018-03-29
JP2018521106A (ja) 2018-08-02
RU2018107054A3 (zh) 2019-08-28
KR20170014059A (ko) 2017-02-08
WO2017018819A1 (en) 2017-02-02
CN106659680A (zh) 2017-05-10
ZA201801186B (en) 2018-12-19

Similar Documents

Publication Publication Date Title
IL289099A (en) Methods for storage of whole blood, and corresponding preparations
EP3130355A4 (en) Pharmaceutical composition containing pregabalin with improved stability and method for preparing same
HUE045195T2 (hu) Pipettahegy-befogadó tartály, valamint eljárás annak elõkészítésére
IL251703A0 (en) A pharmaceutical preparation with improved stability
ZA201703398B (en) Pharmaceutical composition and methods
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
HK1214767A1 (zh) 片劑形式的藥物組合物及其製造方法
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
HK1249439A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
HK1249442A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
RS63790B1 (sr) Farmaceutska kompozicija koja sadrži aprepitant i postupak za pripremu iste
HK1249440A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
EP3305283A4 (en) STABILIZED PHARMACEUTICAL COMPOSITION AND PROCESS FOR PREPARING THE SAME
HK1249441A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
EP3344661C0 (en) IRON POLYSACCHARIDE COMPLEXES AND METHOD FOR THE PRODUCTION THEREOF
ZA201503860B (en) Pharmaceutical composition comprising atomoxetine and method for the preparation thereof
IL230801A0 (en) A solid preparation containing stable sulfur and a method for its production